Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
GT Biopharma, Inc. (GTBP)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
11 Apr 2023
Breen Michael Martin
Executive Chairman/Interim CEO, Director, Officer
GT Biopharma, Inc.
(GTBP)
656,218
+8%
50,000
$0.50
$25,000.00
BUY
6 Apr 2023
Ohri Manu
CFO & Secretary, Officer
GT Biopharma, Inc.
(GTBP)
50,000
+100%
50,000
$0.50
$25,000.00
SELL
21 Dec 2020
Weldon Steven W
Former Officer and Director
GT Biopharma, Inc.
(GTBP)
3,720,000
-0%
10,805.883
$5.82
$62,836.68
SELL
16 Dec 2020
Weldon Steven W
Former Officer and Director
GT Biopharma, Inc.
(GTBP)
3,903,700
-0%
11,764.706
$5.14
$60,500.00
SELL
11 Dec 2020
Weldon Steven W
Former Officer and Director
GT Biopharma, Inc.
(GTBP)
4,203,700
-0%
23,311.766
$4.87
$113,427.00
BUY
16 Nov 2020
Wendel Bruce
Director
GT Biopharma, Inc.
(GTBP)
4,642
+6%
299
$87.96
$26,298.83
SELL
2 Jun 2020
Cataldo Tony
CEO, Director, Officer, 10% Owner
GT Biopharma, Inc.
(GTBP)
6,500,000
-3%
249,077.64
$0.02
$4,234.32
SELL
13 May 2020
Weldon Steven W
CFO, Director, Officer
GT Biopharma, Inc.
(GTBP)
4,500,000
-2%
133,512.23
$0.02
$2,269.71
SELL
6 Feb 2019
Cataldo Tony
Director
GT Biopharma, Inc.
(GTBP)
4,029,600
-1%
47,058.824
$0.02
$800.00
SELL
1 Feb 2019
Urbanski Raymond W.
CEO, Director, Officer
GT Biopharma, Inc.
(GTBP)
1,351,918
-0%
10,410.588
$0.02
$176.98
Home